Total Payments
$2,051
2024 Payments
$858.48
Companies
24
Transactions
104
Medicare Patients
18,642
Medicare Billing
$702,733
Payment Breakdown by Category
Food & Beverage$2,032 (99.1%)
Education$19.15 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,032 | 102 | 99.1% |
| Education | $19.15 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $310.33 | 15 | $0 (2024) |
| Lilly USA, LLC | $256.11 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $254.30 | 16 | $0 (2024) |
| Novo Nordisk Inc | $212.31 | 11 | $0 (2024) |
| PFIZER INC. | $169.16 | 10 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $125.00 | 1 | $0 (2019) |
| Astellas Pharma US Inc | $97.12 | 6 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $83.89 | 4 | $0 (2024) |
| Amgen Inc. | $66.17 | 4 | $0 (2024) |
| Abbott Laboratories | $63.74 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $858.48 | 44 | ABBVIE INC. ($162.35) |
| 2023 | $675.43 | 35 | ABBVIE INC. ($127.73) |
| 2022 | $224.62 | 13 | GlaxoSmithKline, LLC. ($44.89) |
| 2020 | $50.59 | 3 | Janssen Pharmaceuticals, Inc ($30.65) |
| 2019 | $175.57 | 4 | Actelion Pharmaceuticals US, Inc. ($125.00) |
| 2018 | $52.11 | 4 | GlaxoSmithKline, LLC. ($23.04) |
| 2017 | $13.89 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13.89) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Endocrinology | ||||||
| 09/09/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Hematology | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Biological | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: PAIN | ||||||
| 08/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: VACCINES | ||||||
| 08/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Obesity | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes Care | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: PAIN | ||||||
| 06/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Biological | ||||||
| 06/05/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: ADHD | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 64 | 4,363 | 7,701 | $509,503 | $168,329 |
| 2022 | 67 | 4,631 | 8,499 | $526,481 | $176,190 |
| 2021 | 73 | 4,924 | 9,769 | $546,698 | $199,177 |
| 2020 | 74 | 4,724 | 9,269 | $516,354 | $159,037 |
Total Patients
18,642
Total Services
35,238
Medicare Billing
$702,733
Procedure Codes
278
All Medicare Procedures & Services
278 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 372 | 708 | $111,590 | $55,998 | 50.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 96 | 96 | $15,450 | $11,747 | 76.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 190 | 229 | $24,510 | $11,363 | 46.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 111 | 114 | $11,150 | $8,015 | 71.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $11,720 | $7,897 | 67.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 269 | 341 | $23,870 | $5,531 | 23.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 372 | 646 | $9,690 | $5,377 | 55.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 306 | 398 | $23,880 | $4,109 | 17.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 276 | 311 | $21,770 | $4,067 | 18.7% |
| 77067 | Screening mammography | Office | 2023 | 47 | 47 | $15,040 | $3,708 | 24.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 119 | 122 | $4,880 | $3,493 | 71.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 322 | 450 | $18,000 | $3,411 | 19.0% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 20 | 21 | $39,900 | $2,976 | 7.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 14 | $9,240 | $2,895 | 31.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 18 | $8,460 | $2,767 | 32.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 167 | 266 | $11,970 | $2,485 | 20.8% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 14 | 15 | $21,000 | $2,064 | 9.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $2,640 | $1,883 | 71.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 97 | 97 | $3,880 | $1,626 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,625 | $1,570 | 43.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 29 | 42 | $6,300 | $1,510 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,765 | $1,496 | 54.1% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 18 | 18 | $7,470 | $1,467 | 19.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 23 | 24 | $3,840 | $1,207 | 31.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 31 | 38 | $4,180 | $1,102 | 26.4% |
About Dr. Jayson Fields, MD
Dr. Jayson Fields, MD is a Family Medicine healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376603654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jayson Fields, MD has received a total of $2,051 in payments from pharmaceutical and medical device companies, with $858.48 received in 2024. These payments were reported across 104 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,032).
As a Medicare-enrolled provider, Fields has provided services to 18,642 Medicare beneficiaries, totaling 35,238 services with total Medicare billing of $702,733. Data is available for 4 years (2020–2023), covering 278 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cartersville, GA
- Active Since 12/09/2006
- Last Updated 04/23/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376603654
Products in Payments
- VRAYLAR (Drug) $174.19
- MOUNJARO (Drug) $153.64
- TRELEGY ELLIPTA (Drug) $118.73
- NURTEC ODT (Drug) $114.30
- QULIPTA (Drug) $104.58
- AREXVY (Drug) $95.28
- Ozempic (Drug) $93.81
- ACCRUFER (Drug) $83.89
- Rybelsus (Drug) $77.17
- Veozah (Drug) $70.88
- Kerendia (Drug) $63.70
- FREESTYLE LIBRE 3 (Device) $49.35
- ELIQUIS (Drug) $48.41
- TRULICITY (Drug) $44.78
- Wegovy (Drug) $41.33
- JARDIANCE (Drug) $36.23
- EVENITY (Biological) $35.65
- Tymlos (Drug) $33.69
- UBRELVY (Drug) $31.56
- Otezla (Drug) $30.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cartersville
Louis Spencer, M.d, M.D
Family Medicine — Payments: $12,393
Family Medicine $12,393
Dr. Carl Bevill, Md, MD
Family Medicine — Payments: $12,235
Family Medicine $12,235
Mary Barfield, Md, MD
Family Medicine — Payments: $7,612
Family Medicine $7,612
Mr. Lee Battle, Md, MD
Family Medicine — Payments: $6,097
Family Medicine $6,097
Dr. James Williams, Md, MD
Family Medicine — Payments: $5,932
Family Medicine $5,932
Dr. Richard Britton, D.o, D.O
Family Medicine — Payments: $5,359
Family Medicine $5,359